Symbols

MDWD

MediWound·NASDAQ

--(--)

MDWD Profile

Mediwound Ltd.

A fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration

Industry

Pharmaceutical

Established Date

01/27/2000

Listing Date

03/20/2014

Exchange

NASDAQ Stock Exchange

Full-time Employees

121

Fiscal Year Ends

12-31

Website

www.mediwound.com

Security Type

Common stock

Office address

42 Hayarkon Street, Yavne , 8122745 Israel

Business

Introduction

MediWound Ltd., was legally incorporated in Israel on January 27, 2000. The company is a global leader in next-generation enzyme therapies focused on non-surgical tissue repair. The company's solution selectively removes inactive and dangerous tissue while preserving healthy tissue, providing a safer and more effective alternative to traditional methods. With strong internal research, development and manufacturing capabilities, the company manufactures and commercializes cutting-edge biologics for wound and burn care that exceed existing standards of care, improve patient prognosis, and reduce healthcare costs by eliminating the need for surgical intervention.